U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07874841) titled 'Varenicline for Smoking Cessation in Pancreatitis' on Oct. 08.
Brief Summary: This study will look at how safe and how effective varenicline, a commonly used medication for smoking cessation, is in helping patients with pancreatitis stop smoking cigarettes. Individuals who agree to be part of the study will be treated with varenicline for 12 weeks, after which we will see how many have stopped smoking.
Study Start Date: Nov. 13
Study Type: INTERVENTIONAL
Condition:
Pancreatitis
Chronic Pancreatitis
Acute Pancreatitis (AP)
Recurrent Acute Pancreatitis
Intervention:
DRUG: Varenicline (VAR)
Varenicline is the treatment being off...